OR WAIT null SECS
Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.
January 25, 2013
A new international agreement to reduce mercury contamination of air and water was recently adopted by 140 countries, without a proposal that threatened to limit access to vaccines in much of the world.
January 24, 2013
Biopharmaceutical companies are touting their huge investment in R&D, which has filled the drug pipeline with more potential first-in-class medicines, including orphan drugs, personalized medicines and new therapies based on novel scientific strategies.
January 01, 2013
Shortages and compounding disaster spur efforts to overhaul manufacturing oversight and stimulate industry improvements.
December 02, 2012
White House and Congress likely to struggle over funding for bio/pharmaceutical regulation.
November 28, 2012
Recent change likely to boost drug coverage by plans, but with variation in formularies.
November 06, 2012
Efforts to repeal the Affordable Care Act (ACA) died on election day, as President Barack Obama won a second term in the White House and the Democrats maintained control of the Senate.